TransMedics Group, Inc. (NASDAQ:TMDX) Q3 2022 Results Conference Call November 3, 2022 4:30 PM ET Company Participants Brian Johnston - Gilmartin Group Waleed Hassanein - President and CEO Stephen Gordon - CFO Conference Call Participants Allen Gong - J.P. Morgan Cecilia Furlong - Morgan Stanley Joshua Jennings - Cowen Bill Plovanic - Canaccord Suraj Kalia - Oppenheimer Operator Good afternoon, and welcome to TransMedics Third Quarter 2022 Earnings Conference Call. [Operator Instructions] As a reminder, thi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38891 TransMedics Group, Inc. (Exact name of registrant as specified in its charter) Massachusetts 83-2181531 (State or other juri ...

Start Time: 16:30 January 1, 0000 5:16 PM ET TransMedics Group, Inc. (NASDAQ:TMDX) Q2 2022 Earnings Conference Call August 01, 2022, 16:30 PM ET Company Participants Waleed Hassanein - President and CEO Stephen Gordon - CFO Brian Johnston - Gilmartin Group Conference Call Participants Bill Plovanic - Canaccord Genuity Calvin Chu - Morgan Stanley Josh Jennings - Cowen Suraj Kalia - Oppenheimer Allen Gong - JPMorgan Operator Good afternoon, and welcome to TransMedics Second Quarter 2022 Earnings Conference Ca ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38891 TransMedics Group, Inc. 200 Minuteman Road Andover, Massachusetts 01810 (Address of principal executive offices) (Zip code) ...

Transmedics Group, Inc. (NASDAQ:TMDX) Q1 2022 Earnings Conference Call May 3, 2022 5:00 PM ET Company Participants Brian Johnston - Gilmartin Group Waleed Hassanein - President and CEO Stephen Gordon - CFO Conference Call Participants Bill Plovanic - Canaccord Genuity Cecilia Furlong - Morgan Stanley Josh Jennings - Cowen Allen Gong - JPMorgan Mike Ott - Oppenheimer Operator Good afternoon and welcome to TransMedics First Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen- ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-38891 TransMedics Group, Inc. (Exact name of Registrant as specified in its Charter) Massachusetts 83-2181531 (State or other jurisdiction ...

Transmedics Group, Inc. (NASDAQ:TMDX) Q4 2021 Earnings Conference Call February 23, 2022 5:00 PM ET Company Participants Brian Johnston - Gilmartin Group Waleed Hassanein - Founder, MD, CEO, President & Director Stephen Gordon - CFO. Treasurer & Secretary Conference Call Participants William Plovanic - Canaccord Genuity Michael Ott - Oppenheimer Bryan Bergin - Cowen Operator Good afternoon, and welcome to TransMedics Fourth Quarter and Full Year 2021 Earnings Conference Call. [Operator Instructions]. As a r ...

TransMedics Group, Inc. (NASDAQ:TMDX) Q3 2021 Earnings Conference Call November 9, 2021 4:30 PM ET Company Participants Brian Johnston - VP, IR Waleed Hassanein - President and CEO Stephen Gordon - CFO Conference Call Participants Bill Plovanic - Canaccord Allen Gong - JPMorgan Calvin Chu - Morgan Stanley Brian Kennedy - Cowen and Co. Suraj Kalia - Oppenheimer Operator Good afternoon, and welcome to TransMedics' Third Quarter 2021 Earnings Conference Call. At this time, all participants are in a listen-only ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38891 TransMedics Group, Inc. (Exact name of registrant as specified in its charter) Massachusetts 83-2181531 (State or other ...

TransMedics Group, Inc. (NASDAQ:TMDX) Q2 2021 Earnings Conference Call August 5, 2021 4:30 PM ET Company Participants Brian Johnston - Vice President, Investor Relations Waleed Hassanein - President & Chief Executive Officer. Stephen Gordon - CFO, Treasurer & Secretary Conference Call Participants Cecilia Furlong - Morgan Stanley Josh Jennings - Cowen Bill Plovanic - Canaccord Mike Ott - Oppenheimer Operator Good afternoon, and welcome to TransMedics Second Quarter 2021 Earnings Conference Call. At this tim ...